Seung U. Seo

Daegu, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Selective Modulation of OTUB1 Noncanonical Function via a bioPhosTAC Strategy.

Selective Modulation of OTUB1 Noncanonical Function via a bioPhosTAC Strategy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 03, 2026

Deubiquitinase YOD1 Inhibition Suppresses DEX- and Denervation-Induced Muscle Atrophy Through MAFbx Destabilization.

Deubiquitinase YOD1 Inhibition Suppresses DEX- and Denervation-Induced Muscle Atrophy Through MAFbx Destabilization.

Journal: Journal of cachexia, sarcopenia and muscle

Published: January 13, 2026

Inhibition of UBE2N enhances TRAIL-mediated apoptosis through upregulation of DR5 in cancer cells.

Inhibition of UBE2N enhances TRAIL-mediated apoptosis through upregulation of DR5 in cancer cells.

Journal: International journal of medical sciences

Published: December 19, 2025

Cathepsin L deletion enhances sensitivity to anticancer drugs through Parkin-mediated ubiquitination of Bcl-xL and USP53-induced Survivin destabilization.

Cathepsin L deletion enhances sensitivity to anticancer drugs through Parkin-mediated ubiquitination of Bcl-xL and USP53-induced Survivin destabilization.

Journal: Cell death and differentiation

Published: November 19, 2025

Zerumbone enhances TRAIL-induced apoptosis via USP9x-mediated downregulation of Mcl-1.

Zerumbone enhances TRAIL-induced apoptosis via USP9x-mediated downregulation of Mcl-1.

Journal: Biochemical and biophysical research communications

Published: May 31, 2025

Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer.

Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer.

Journal: Biomaterials

Published: February 04, 2024

Non-canonical deubiquitination of OTUB1 induces IFNγ-mediated cell cycle arrest via regulation of p27 stability.

Non-canonical deubiquitination of OTUB1 induces IFNγ-mediated cell cycle arrest via regulation of p27 stability.

Journal: Oncogene

Published: January 10, 2024

Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin.

Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin.

Journal: International journal of molecular sciences

Published: June 20, 2023

Tubeimoside-1 Enhances TRAIL-Induced Apoptotic Cell Death through STAMBPL1-Mediated c-FLIP Downregulation.

Tubeimoside-1 Enhances TRAIL-Induced Apoptotic Cell Death through STAMBPL1-Mediated c-FLIP Downregulation.

Journal: International journal of molecular sciences

Published: May 29, 2023

Cathepsin D promotes polarization of tumor-associated macrophages and metastasis through TGFBI-CCL20 signaling.

Cathepsin D promotes polarization of tumor-associated macrophages and metastasis through TGFBI-CCL20 signaling.

Journal: Experimental & molecular medicine

Published: February 11, 2023

Cathepsin K inhibition induces Raptor destabilization and mitochondrial dysfunction via Syk/SHP2/Src/OTUB1 axis-mediated signaling.

Cathepsin K inhibition induces Raptor destabilization and mitochondrial dysfunction via Syk/SHP2/Src/OTUB1 axis-mediated signaling.

Journal: Cell death & disease

Published: January 01, 2023

Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5.

Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5.

Journal: Cell death & disease

Published: June 08, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026